share_log

ArriVent BioPharma, Inc. | 3: Initial statement of beneficial ownership of securities-Officer Kastenmayer James Paul

SEC announcement ·  Jan 25 20:41
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more